Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

M. Somlyay, E. Durinikova, J. Besnard, O. Barbeau, J. Le Coz, M. Senekowitsch, B. Ergüner, K. Hackner, L. Dzurillova, E. Petru, J. Lafleur, J. Singer, T. Füreder, R. Paveley, J. Joseph, F. Aswad, T. Winkler-Penz, R. Sehlke, C. Boudesco, G. Vladimer

Research output: Journal article (peer-reviewed)Conference contribution to journal

Original languageEnglish
Pages (from-to)S44-S45
JournalEuropean Journal of Cancer
Publication statusPublished - Oct 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this